SCHEMBL23318901

SCHEMBL23318901

CCC1CNCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL84790 0.87
Hydrochloric Acid SCHEMBL16794147 0.84
SCHEMBL2910711 0.81
SCHEMBL24966685 0.77 SMN1; SMN2 (0.35)
SCHEMBL6984639 0.75 CCR5 (0.32)
SCHEMBL1547371 0.75 CCR5 (0.32)
SCHEMBL5228403 0.75 CCR5 (0.32)
SCHEMBL10074747 0.73
Hydrochloric Acid SCHEMBL5671841 0.73 CHRNB2 (0.30)
Hydrochloric Acid SCHEMBL5671844 0.73 CHRNB2 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230037255-A1 NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS INFLAZOME LTD (IE) 2023-02-02 US disclosed
US-20210130301-A1 COMPOSITIONS FOR THE TREATMENT OF PULMONARY FIBROSIS VECTUS BIOSYSTEMS LIMITED (AU) 2021-05-06 US disclosed